Numlock News: December 20, 2019 • Sugar, Podcasts, Robocalls
www.numlock.com
By Walt Hickey Have a great weekend! Ebola The FDA has approved an Ebola vaccine, following a similar approval from the European Commission in November, and making it the first-ever approved Ebola vaccination in the United States. Gavi, the Vaccine Alliance announced plans to accumulate a 500,000-dose stockpile for worldwide emergencies, and the United States is also expected to be one of many countries that stockpiles the vaccine as a bioterrorism defense. Merck, the developer of the drug, will qualify for a tropical disease priority review voucher, which is basically good for one fast-tracked FDA review of a future drug or vaccine, an incentive that was created to kick off development of treatments for neglected, underfunded diseases. They can be sold, too: In December, a priority review voucher was sold by Bavarian Nordic for
Numlock News: December 20, 2019 • Sugar, Podcasts, Robocalls
Numlock News: December 20, 2019 • Sugar…
Numlock News: December 20, 2019 • Sugar, Podcasts, Robocalls
By Walt Hickey Have a great weekend! Ebola The FDA has approved an Ebola vaccine, following a similar approval from the European Commission in November, and making it the first-ever approved Ebola vaccination in the United States. Gavi, the Vaccine Alliance announced plans to accumulate a 500,000-dose stockpile for worldwide emergencies, and the United States is also expected to be one of many countries that stockpiles the vaccine as a bioterrorism defense. Merck, the developer of the drug, will qualify for a tropical disease priority review voucher, which is basically good for one fast-tracked FDA review of a future drug or vaccine, an incentive that was created to kick off development of treatments for neglected, underfunded diseases. They can be sold, too: In December, a priority review voucher was sold by Bavarian Nordic for